Detalhe da pesquisa
1.
Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology.
Ther Drug Monit
; 46(3): 291-308, 2024 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38648666
2.
Identifying risk factors of anti-TNF induced skin lesions and other adverse events in paediatric patients with inflammatory bowel disease.
J Pediatr Gastroenterol Nutr
; 78(1): 95-104, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38291690
3.
Ceftriaxone dosing based on the predicted probability of augmented renal clearance in critically ill patients with pneumonia.
J Antimicrob Chemother
; 77(9): 2479-2488, 2022 08 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35815604
4.
Infliximab Concentrations during Induction Are Predictive for Endoscopic Remission in Pediatric Patients with Inflammatory Bowel Disease under Combination Therapy.
J Pediatr
; 240: 150-157.e4, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34481805
5.
Population pharmacokinetic-pharmacodynamic model-based exploration of alternative ustekinumab dosage regimens for patients with Crohn's disease.
Br J Clin Pharmacol
; 88(1): 323-335, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34197653
6.
Liposomal amphotericin B exposure in critically ill patients: a prospective pharmacokinetic study.
Med Mycol
; 60(10)2022 Oct 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36124725
7.
Therapeutic drug monitoring in dermatology: the way towards dose optimization of secukinumab in chronic plaque psoriasis.
Clin Exp Dermatol
; 47(7): 1324-1336, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35245966
8.
Exposure to intravenous posaconazole in critically ill patients with influenza: A pharmacokinetic analysis of the POSA-FLU study.
Mycoses
; 65(6): 656-660, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35437848
9.
Peak Concentrations of Ustekinumab After Intravenous Induction Therapy Identify Patients With Crohn's Disease Likely to Achieve Endoscopic and Biochemical Remission.
Clin Gastroenterol Hepatol
; 19(1): 111-118.e10, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32109630
10.
Infliximab Exposure Associates With Radiologic Evidence of Healing in Patients With Crohn's Disease.
Clin Gastroenterol Hepatol
; 19(5): 947-954.e2, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32360982
11.
Bosentan Alters Endo- and Exogenous Bile Salt Disposition in Sandwich-Cultured Human Hepatocytes.
J Pharmacol Exp Ther
; 379(1): 20-32, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34349015
12.
Population pharmacokinetics of cefazolin in maternal and umbilical cord plasma, and simulated exposure in term neonates.
J Antimicrob Chemother
; 76(12): 3229-3236, 2021 11 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34499720
13.
Pharmacokinetics and target attainment of intravenous posaconazole in critically ill patients during extracorporeal membrane oxygenation.
J Antimicrob Chemother
; 76(5): 1234-1241, 2021 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33517360
14.
Modelling of the relationship between infliximab exposure, faecal calprotectin and endoscopic remission in patients with Crohn's disease.
Br J Clin Pharmacol
; 87(1): 106-118, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32415677
15.
The effect of aging on infliximab exposure and response in patients with inflammatory bowel diseases.
Br J Clin Pharmacol
; 87(10): 3776-3789, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33604964
16.
A Population Pharmacokinetic Modeling and Simulation Study of Posaconazole Oral Suspension in Immunocompromised Pediatric Patients: A Short Communication.
Ther Drug Monit
; 43(4): 512-518, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33560094
17.
Concomitant use of isavuconazole and CYP3A4/5 inducers: Where pharmacogenetics meets pharmacokinetics.
Mycoses
; 64(9): 1111-1116, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33963620
18.
How, When, and for Whom Should We Perform Therapeutic Drug Monitoring?
Clin Gastroenterol Hepatol
; 18(6): 1291-1299, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31589978
19.
Monitoring a Combination of Calprotectin and Infliximab Identifies Patients With Mucosal Healing of Crohn's Disease.
Clin Gastroenterol Hepatol
; 18(3): 637-646.e11, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31128336
20.
Optimising infliximab induction dosing for patients with ulcerative colitis.
Br J Clin Pharmacol
; 85(4): 782-795, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30634202